Sean Misek
Harvard University
H-index: 7
North America-United States
Top articles of Sean Misek
DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA
Neuro-Oncology
2023/11/1
Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation
2023/6/1
Rapid label-free imaging-based evaluation of cancer dependencies in zero-passage primary cells
Cancer Research
2023/4/4
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade
bioRxiv
2023
Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries
bioRxiv
2022/11/19
Rapidly evaluating cancer dependencies by label-free imaging of zero-passage primary cells
Cancer Research
2022/6/15
Ancestry bias in CRISPR guide design impedes discovery of genetic dependencies
Cancer Research
2022/6/15
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
Neuro-Oncology
2022/6
BRAF inhibitor resistance confers increased sensitivity to mitotic inhibitors
Frontiers in Oncology
2022/4/4
Ibrutinib blocks YAP1 activation and reverses BRAF inhibitor resistance in melanoma cells
Molecular Pharmacology
2022/1/1
Genome-scale CRISPR screen finds prostate lineage specific dependencies
Cancer Research
2021/7/1
Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines
Cancers
2021/4/22
Abstract PO-093: Evaluating dependencies by rapid image-based ex vivo cancer biosensors
Clinical Cancer Research
2021/3/1
Abstract B07: Rho-mediated gene transcription promotes BRAFi resistance in de-differentiated melanoma cells
Cancer Research
2020/10/1
Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
Oncogene
2020/2/13
Identification of Pharmacological Vulnerabilities in Drug-Resistant Melanoma Cells
2020
